Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer

Study ID
NCT00947102

Study type
Observational

Study phase

Study status
Unknown status

Trial Acronym

GEMSTHER

Trial Summary

Observational study of influence of gemcitabine treatment on serological and immunological status and gene expression profile in patients with pancreatic tubular carcinoma after tumor resection.

More informations

Trial Starting Date

Feb 28,2009

Requirements

Gender All
Minimum age 30 Years
Maximum age 85 Years

Enrollement Limit